Where Is Compounded Semaglutide Actually Made? An Honest Look at the Supply Chain

Important Disclaimer: Compounded semaglutide is NOT FDA-approved. The FDA does not review or verify the safety, effectiveness, or quality of compounded medications, and compounded semaglutide has NOT been shown to be equivalent or interchangeable with FDA-approved Ozempic or Wegovy. A pharmacy’s state license, a facility’s FDA registration, or the phrase “made in the USA” is NOT the same as FDA approval of the medication. This article is for educational purposes only and is not medical advice. Talk with a licensed healthcare provider about whether any treatment is appropriate for you.

If you have been searching for an honest answer to one specific, anxious question — where does my compounded semaglutide actually come from? — this guide is written for you. We will walk the supply chain from raw active ingredient to the vial in your hand, name the parts that make people uncomfortable (including where active ingredients are often manufactured and what the FDA has flagged about certain chemical forms), and explain how you can verify the origin of your own medication. No hype, no fear-mongering — just the facts and the questions worth asking.

Why this question matters (and why nobody answers it plainly)

You are injecting this medication into your body, often weekly, for months. It is completely reasonable to want to know where it came from — not in vague marketing language, but concretely: who made the active ingredient, who turned it into an injectable solution, and what oversight applied along the way.

Most marketing pages avoid the question. They lean on reassuring phrases — “pharmaceutical-grade,” “U.S. pharmacy,” “FDA-registered facility” — that sound like an answer without actually being one. Some of those phrases are meaningful. Several are easy to misread. And the honest, complete answer includes a few facts the industry would rather skip past, such as the reality that the active ingredient in many medications — brand-name and compounded alike — is frequently manufactured outside the United States, including in China and India.

We are going to say the uncomfortable parts out loud, because a calm, complete answer is more useful to an anxious buyer than a polished one with the hard parts removed. Knowing where your medication comes from does not, by itself, make it safe — but it does let you ask better questions and make a more informed decision with your prescriber.

One framing matters before we start. Compounded semaglutide is prepared because a licensed clinician determines that an individual patient has a specific clinical need that a compounded preparation can address, based on a valid prescription. That is the lawful basis for compounding, and it is the lens through which everything below should be read.

How the compounded semaglutide supply chain works (API → pharmacy → you)

Compounded semaglutide travels through a chain of distinct steps. Understanding the chain is the first step to knowing where any single dose came from.

Step 1: API manufacturing

It begins with the Active Pharmaceutical Ingredient (API) — the raw semaglutide itself. API is produced by specialized chemical and biologics manufacturers, not by the pharmacy that fills your prescription. These manufacturers produce the active substance in bulk and ship it to pharmacies and distributors.

Step 2: Sourcing and incoming verification

A compounding pharmacy obtains semaglutide API from a supplier. A careful pharmacy verifies the API’s origin, confirms the supplier’s regulatory standing, and reviews documentation — most importantly a Certificate of Analysis (COA) for the specific lot, which reports identity, purity, and potency.

Step 3: Compounding (formulation and sterile preparation)

The pharmacy combines the API with other ingredients — typically a sterile diluent and sometimes a preservative — to prepare an injectable solution. Because semaglutide is injected, this must happen under sterile conditions consistent with USP Chapter <797> for sterile compounding, in a controlled cleanroom environment using aseptic technique.

Step 4: Quality control

Depending on the pharmacy and the applicable standards, quality control may include sterility testing, endotoxin testing, and potency testing. Practices and frequency vary between pharmacies, and compounded products are not subject to the FDA’s pre-market product review.

Step 5: Dispensing and shipping to you

The finished, labeled preparation is dispensed against a valid, patient-specific prescription and shipped — ideally with cold-chain handling, since semaglutide generally requires refrigeration.

Stage	Who is responsible	What to verify
API manufacturing	Bulk API manufacturer (often overseas)	FDA-registered API source; Certificate of Analysis
Sourcing	Compounding pharmacy	Supplier vetting; incoming lot testing
Compounding	Licensed 503A compounding pharmacy	State license; USP <797> sterile compliance
Quality control	Pharmacy / contracted lab	Sterility, endotoxin, potency testing
Dispensing	Pharmacy + prescriber	Valid prescription; cold-chain shipping

The single most important takeaway: the pharmacy whose name is on your label is usually not the company that made the active ingredient. When you ask “where is it made?”, you are really asking two questions — where the API was manufactured, and where it was compounded into a finished product.

The API question — where the active ingredient comes from and why source matters

This is the part most pages skip, so we will be direct.

A large share of the world’s pharmaceutical active ingredients — for both brand-name and compounded medications — is manufactured outside the United States, with China and India being major global producers of APIs and their chemical precursors. This is not unique to semaglutide or to compounding; it reflects how the global pharmaceutical supply chain has been structured for decades. The U.S. Food and Drug Administration itself has repeatedly noted heavy reliance on overseas API manufacturing across the drug supply.

So the honest answer to “is the active ingredient sometimes made overseas?” is: yes, frequently — and that overseas origin, on its own, is neither a secret nor automatically a danger. What matters is whether the API came from a manufacturer operating within a recognized regulatory framework and whether its identity, purity, and potency were verified.

What “FDA-registered API source” does and does not mean

Foreign and domestic facilities that manufacture API for the U.S. market are expected to register with the FDA and are subject to FDA inspection. A reputable compounding pharmacy sources semaglutide API from suppliers that register with the FDA, follow Current Good Manufacturing Practice (cGMP) for the API, meet United States Pharmacopeia (USP) purity standards, and provide a Certificate of Analysis for each lot.

But read this carefully: an FDA-registered API manufacturer, or a U.S.-based compounding pharmacy, is not the same as an FDA-approved medication. Registration means a facility is on the FDA’s list and subject to oversight; it is not FDA review of your specific finished product for safety and effectiveness. “Made in the USA,” “FDA-registered facility,” and “pharmaceutical-grade” are all distinct from — and weaker than — “FDA-approved.” We say this plainly because the difference is exactly where confusion (and false reassurance) lives.

Why the source genuinely matters

• Identity: Verification confirms the material actually is semaglutide and is the intended chemical form.
• Purity: Testing checks for impurities and contaminants that should not be present in an injectable.
• Potency: A COA reports the measured concentration so the finished product can be dosed accurately.
• Traceability: A documented chain from a registered manufacturer makes it possible to trace and, if needed, recall a specific lot.

The opposite of this is the genuinely risky scenario: semaglutide-labeled powder sold by unverified “research-only” suppliers, with no registration, no COA, and no traceability. That is a different universe from API obtained from a registered manufacturer and verified by a licensed pharmacy — even when that manufacturer is located overseas.

Semaglutide salt forms vs base — what the FDA flagged and what to ask

There is a specific, technical detail here that received regulatory attention, and you deserve a factual explanation rather than either silence or alarm.

Semaglutide can exist in different chemical forms. The form used in the FDA-approved products is the semaglutide base. Some compounded preparations have, at times, been made using salt forms of semaglutide — such as semaglutide sodium or semaglutide acetate. The FDA has cautioned that these salt forms are different substances from the base semaglutide in the approved drugs, and that their safety and effectiveness in compounded products have not been established. In other words, “semaglutide sodium” is not simply interchangeable with the semaglutide in Ozempic or Wegovy.

We are not making a product claim here, and nothing in this section asserts that any particular preparation is equivalent to an approved drug — it is not. The practical, factual point for you is simply this: it is reasonable to ask your provider and pharmacy whether the base form of semaglutide is used in any preparation you are considering, and to ask for documentation. A pharmacy that can answer this clearly and back it with a Certificate of Analysis is demonstrating exactly the kind of transparency that this whole article is about.

Questions worth asking about chemical form

• “Is this preparation made with semaglutide base, or with a salt form such as sodium or acetate?”
• “Can you provide a Certificate of Analysis that identifies the chemical form and the API source?”
• “How do you verify the identity of the API on incoming lots?“

503A compounding pharmacies — who makes your medication and what oversight applies

“Who compounds it” is the other half of the provenance question. Under section 503A of the Federal Food, Drug, and Cosmetic Act, state-licensed compounding pharmacies prepare medications for an individual patient pursuant to a valid prescription (Source: FDA).

503A compounding pharmacies (patient-specific)

• Regulation: State boards of pharmacy, under federal and state law (the FDA retains certain authority)
• Scope: Prepare medications for an individual patient pursuant to a valid prescription
• Standards: Follow USP standards including USP <795> (non-sterile) and USP <797> (sterile) as applicable
• Use case: A patient with a documented, patient-specific clinical need determined by a licensed clinician

The key point for provenance: a 503A compounding pharmacy does not produce an FDA-approved medication. A 503A pharmacy’s state license signals it operates within a regulated framework, not that the finished product is FDA-reviewed. Knowing that a state-licensed 503A compounding pharmacy made your medication tells you which oversight framework applied — it does not convert a compounded preparation into an approved one.

How to find out where YOUR medication comes from

You do not have to take anyone’s word for it. Provenance is verifiable if you know what to ask and where to look. The following is a checklist for evaluation — not a guarantee of any outcome.

Questions to ask your provider and pharmacy

• “Which licensed pharmacy compounds my semaglutide, and in which state is it licensed?”
• “Is it a 503A patient-specific compounding pharmacy?”
• “Where is the semaglutide API manufactured, and is the supplier FDA-registered?”
• “Is the preparation made with the base form of semaglutide?”
• “Can you provide a Certificate of Analysis for my lot?”
• “Do you perform sterility, endotoxin, and potency testing?”
• “What is the beyond-use date, and how should I store and handle it?”

How to verify the answers

• Certificate of Analysis (COA): A lot-specific COA reports identity, purity, and potency. A pharmacy willing to provide one is demonstrating transparency; one that cannot or will not is a red flag.
• State board of pharmacy: You can confirm a pharmacy’s license status and look for disciplinary history through the relevant state board of pharmacy.
• NABP: The National Association of Boards of Pharmacy operates verification resources you can use to check a pharmacy’s accreditation status and standing.
• FDA records: You can check the FDA’s databases for warning letters and recalls associated with a facility.

Sources to avoid entirely

• ❌ Sellers that are not licensed U.S. pharmacies and have no verifiable oversight
• ❌ “Research-only” or non-pharmaceutical-grade material sold for human use
• ❌ Sources that do not require a valid prescription from a licensed provider
• ❌ Sellers that cannot or will not provide a Certificate of Analysis or quality documentation
• ❌ Sources that make guaranteed-outcome promises or skip cold-chain shipping

How Contour Health approaches provenance

Given everything above, here is how Contour Health approaches the question of where your medication comes from. We are describing our process, not making safety guarantees.

Contour works with WellSync and other state-licensed 503A compounding pharmacies in the WellSync network. The pharmacies in this network prepare semaglutide for an individual patient pursuant to a valid prescription, under USP <795>/<797> standards, and source semaglutide API from suppliers that register with the FDA and provide a Certificate of Analysis. A licensed clinician determines whether a compounded preparation is appropriate for a patient’s specific clinical situation before anything is prescribed.

We want to be measured and honest about what this does and does not mean:

• Vetting suppliers, using licensed U.S. pharmacies, and reviewing documentation can reduce certain risks — particularly the risks tied to unverified, untraceable sources. It does not eliminate risk, and we do not claim it does.
• Compounded semaglutide is not FDA-approved and has not been shown to be equivalent or interchangeable with Ozempic or Wegovy. The fact that a pharmacy is U.S.-based and state-licensed does not change that.
• A facility’s registration or license is not FDA approval of the medication.

What we will commit to is transparency: telling you plainly how your medication is sourced and prepared, and supporting your right to ask the questions in the section above. If you want to see how that process works in practice, you can explore Contour’s weight-loss program and discuss it with a licensed provider. For broader background, our compounded semaglutide safety guide and our explainer on whether compounded semaglutide is FDA-approved go deeper on the regulatory picture.

Boxed Warning: Risk of Thyroid C-Cell Tumors

The FDA-approved semaglutide products Ozempic and Wegovy carry a Boxed Warning regarding the risk of thyroid C-cell tumors, based on findings in rodent studies; it is not known whether semaglutide causes such tumors, including medullary thyroid carcinoma (MTC), in humans. Because compounded semaglutide uses the same active molecule, the same thyroid C-cell tumor concern described in that labeling is relevant to it; compounded semaglutide is not FDA-approved and has no FDA-reviewed labeling of its own. Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider about any personal or family history of thyroid cancer or MEN 2 before considering any semaglutide product. This warning is attributed to the FDA-approved product labeling for Ozempic and Wegovy.

Frequently Asked Questions

Where do compounding pharmacies get the API for semaglutide?

Compounding pharmacies obtain semaglutide as a bulk active ingredient from API manufacturers, then verify it before use. Reputable pharmacies source from suppliers that register with the FDA, follow cGMP for the API, meet USP purity standards, and provide a Certificate of Analysis for each lot. The pharmacy that fills your prescription is generally not the company that manufactured the API.

Is compounded semaglutide made in China?

The active ingredient may be. A large share of pharmaceutical API for the U.S. market — for both brand-name and compounded drugs — is manufactured overseas, with China and India among the major global producers. Overseas origin alone is not automatically unsafe; what matters is whether the manufacturer is FDA-registered and operating within a recognized framework, and whether the API’s identity, purity, and potency were verified with a Certificate of Analysis. The compounding itself, however, may be performed by a U.S.-licensed pharmacy.

What is the difference between semaglutide salt and base?

Semaglutide can exist in different chemical forms. The FDA-approved products use the semaglutide base. Some compounded preparations have at times used salt forms such as semaglutide sodium or semaglutide acetate. The FDA has cautioned that these salt forms are different substances from the base, and their safety and effectiveness in compounded products have not been established, and a salt form is not interchangeable with the semaglutide in the FDA-approved products. It is reasonable to ask whether the base form is used and to request documentation. None of this means any compounded preparation is equivalent to an FDA-approved drug.

How do I find out where my compounded semaglutide is made?

Ask your provider and pharmacy which licensed 503A compounding pharmacy compounds it, where the API is sourced, and whether they can provide a Certificate of Analysis. You can verify a pharmacy’s license through its state board of pharmacy, use NABP verification resources, and check the FDA’s records for warning letters or recalls.

Is US-compounded semaglutide safer than imported?

Using a state-licensed U.S. pharmacy that requires a valid prescription, follows USP <797>, and documents testing can reduce certain risks compared with unverified or “research-only” imported products — but it does not eliminate risk, and it does not make the medication FDA-approved or equivalent to Ozempic or Wegovy. “Made in the USA” or “FDA-registered facility” is not the same as FDA approval of the medication. Safety also depends on the API source, the chemical form, testing, storage, and appropriate medical oversight.

Related Articles

• Is Compounded Semaglutide Safe? What You Should Know
• Is Compounded Semaglutide FDA-Approved?
• The Complete Guide to Semaglutide
• Microdosing Semaglutide: What to Know